 |
 |
外科学论文:原发性骨质疏松症治疗药物及疗效随访原则
关键词 原发性骨质疏松症 诊治指南 药物治疗
中图分类号：R977 文献标识码：C 文章编号：1006-1533（2013)09-0001-05
Drugs in the treatment of primary
osteoporosis and the following-up principles of their efficacy
Zhang Zhenlin
（Metabolic Bone Disease and Genetic Research Unit， Department of Osteoporosis and Bone Disease，
Sixth People’s Hospital， Shanghai Jiao Tong University， Shanghai 200233， China)
ABSTRACT According to the updated Guidelines for the Diagnosis and Treatment of Primary Osteoporosis written mainly by the Panch of Osteoporosis and Bone Mineral Diseases of the Chinese Medical Society， this article introduces the drugs in the treatment of primary osteoporosis and the following-up principles of their efficacy so as to help the clinical doctors standardize the application of the drugs to prevent and treat osteoporosis.
Key Words primary osteoporosis； guideline for the diagnosis and treatment； pharmaceutical treatment
骨质疏松症是一种因骨量低下、骨微结构破坏而致骨脆性增加并易发生骨折的全身性骨病，常见于绝经后妇女和老年男性。骨质疏松症分为原发性和继发性两类。原发性骨质疏松症又可再分为绝经后骨质疏松症、老年性骨质疏松症和特发性骨质疏松症。本文主要依据中华医学会骨质疏松和骨矿盐疾病分会2011年发布的新版《原发性骨质疏松诊治指南》[1]，就原发性骨质疏松症治疗药物及疗效随访原则进行介绍，以期帮助临床医生规范应用骨质疏松症防治药物医.学全.在.线网站www.lindalemus.com。
1 防治目的
骨质疏松症初级预防是指对尚无骨质疏松、但具有骨质疏松症危险因素者应防止或延缓其发展为骨质疏松症并避免发生第1次骨折；骨质疏松症二级预防是指对已患骨质疏松症或T值≤-2.5、或已发生过脆性骨折者的防治目的是避免发生或再次发生骨折。
2 应用药物
完整的骨质疏松症防治策略包括基础措施、药物干预和康复治疗。本文主要介绍药物干预部分。
